Where do we go after GiACTA?
- PMID: 35020808
- DOI: 10.1093/rheumatology/keac010
Where do we go after GiACTA?
Comment on
-
New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extension.Rheumatology (Oxford). 2022 Jul 6;61(7):2915-2922. doi: 10.1093/rheumatology/keab780. Rheumatology (Oxford). 2022. PMID: 34718434 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
